Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for INCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2023 226.85M
March 31, 2023 243.20M
December 31, 2022 271.51M
September 30, 2022 245.94M
June 30, 2022 226.45M
March 31, 2022 233.05M
December 31, 2021 223.80M
September 30, 2021 203.22M
June 30, 2021 180.60M
March 31, 2021 102.82M
December 31, 2020 101.62M
September 30, 2020 93.81M
June 30, 2020 74.50M
March 31, 2020 68.03M
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
Date Value
March 31, 2017
December 31, 2016 7.21M
September 30, 2016 5.136M
June 30, 2016 4.357M
March 31, 2016 4.588M
December 31, 2015 3.233M
September 30, 2015 3.51M
June 30, 2015 3.94M
March 31, 2015 4.143M
December 31, 2014 0.678M
September 30, 2014 0.804M
June 30, 2014 1.293M
March 31, 2014 1.512M
December 31, 2013 1.77M
September 30, 2013 2.783M
June 30, 2013 3.127M
March 31, 2013 3.489M
December 31, 2012 3.889M
September 30, 2012 3.34M
June 30, 2012 0.411M
March 31, 2012 0.568M
December 31, 2011 0.767M
September 30, 2011 0.909M
June 30, 2011 1.162M
March 31, 2011 1.326M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
IM Cannabis Corp. 17.40M
Teva Pharmaceutical Industries Ltd. 39.86B
RedHill Biopharma Ltd. --
MediWound Ltd. 71.88M
Purple Biotech Ltd. 14.17M